Postimplantation pocket hematoma increases risk of cardiac implantable electronic device infection: A meta-analysis

Jakrin Kewcharoen1, Chanavuth Kanitsoraphan1, Sittinun Thangjui2

  • 1University of Hawaii Internal Medicine Residency Program Honolulu HI USA.

Journal of Arrhythmia
|June 18, 2021
PubMed

Insights

Postimplantation pocket hematoma significantly elevates the risk of cardiac implantable electronic device (CIED) infection. Careful device implantation can help prevent hematoma and subsequent CIED infections.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Medical Device Technology

Background:

  • The relationship between postimplantation pocket hematoma and cardiac implantable electronic device (CIED) infection remains inconsistent in existing literature.
  • Hematomas occurring after device implantation are a potential concern for infection development.

Purpose of the Study:

  • To systematically review and perform a meta-analysis to clarify the effect of postimplantation hematoma on the risk of CIED infection.

Main Methods:

  • A comprehensive search of MEDLINE and EMBASE databases was conducted up to March 2020.
  • Included studies encompassed cohort, case-control, cross-sectional, and randomized controlled trials reporting on hematoma and CIED infection incidence.
  • Data were synthesized using a random-effects model to calculate odds ratios (OR) and 95% confidence intervals (CI).

Main Results:

  • The analysis included 14 studies with 28,319 participants.
  • Postimplantation pocket hematoma was found to significantly increase the risk of overall CIED infection (OR = 6.30, 95% CI: 3.87-10.24).
  • No significant publication bias or small-study effect was detected.

Conclusions:

  • This meta-analysis confirms that postimplantation pocket hematoma is a significant risk factor for CIED infection.
  • Implementing precautions during device implantation to minimize hematoma formation is crucial for preventing subsequent infections.
Abstract

Related Concept Videos

Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
111
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
71
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
105